Investor · NEW YORK, NY

Mona Ashiya

Open Mona in the network graph →

Filings

6

SEC Form D

Connections

26

co-filers

Capital

$193.0M

across filings

Active

Mar 2018

to Sep 2025

Most-connected co-filers (26)

James Sullivan · Berkshire, United Kingdom3 shared Jonathan T. Silverstein · New York, NY3 shared Carl L. Gordon · New York, NY3 shared Geoffrey C. Hsu · New York, NY2 shared David P. Bonita · New York, NY2 shared W. C. Neild · New York, NY2 shared C. S. Stevens · New York, NY2 shared Peter A. Thompson · New York, NY2 shared Sven H. Borho · New York, NY2 shared Matthew S. Rizzo · New York, NY2 shared Bernard J. Davitian · CAMBRIDGE, MA2 shared Peter Thompson · New York, NY1 shared OrbiMed Advisors LLC · New York, NY1 shared Orbimed Capital Gp X Llc · New York, NY1 shared Orbimed Capital Gp X, Lp · New York, NY1 shared Orbimed Advisors Llc · New York, NY1 shared Sara J. Nayeem · CAMBRIDGE, MA1 shared Orbimed Capital Gp X Llc · New York, NY1 shared Orbimed Capital Gp X, Lp · New York, NY1 shared Uya Chuluunbaatar · Chicago, IL1 shared Rand Sutherland · Chicago, IL1 shared Viola Meehan · Chicago, IL1 shared OrbiMed Genesis GP LLC · New York, NY1 shared Asa Abeliovich · NEW YORK, NY1 shared

Recent filings (6)

OrbiMed Genesis Fund, L.P.Dec 2025 · 13 co-filers OrbiMed Genesis Fund, L.P.Dec 2025 · 13 co-filers OrbiMed Private Investments X, LPSep 2025 · 15 co-filers$1.8B OrbiMed Private Investments X, LPSep 2025 · 15 co-filers$1.8B VANQUA BIO, INC.Jul 2024 · 11 co-filers$45.0M VANQUA BIO, INC.Jul 2024 · 11 co-filers$45.0M VANQUA BIO, INC.Sep 2021 · 13 co-filers$85.0M VANQUA BIO, INC.Sep 2021 · 13 co-filers$85.0M SURMOUNT BIO, INC.Oct 2019 · 5 co-filers$18.0M SURMOUNT BIO, INC.Oct 2019 · 5 co-filers$18.0M Prevail Therapeutics Inc.Mar 2018 · 8 co-filers$65.0M Prevail Therapeutics Inc.Mar 2018 · 8 co-filers$65.0M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Mona in the interactive graph →